Implementation and evaluation of a once-daily amikacin dosing protocol in a long-term care facility.
Yoshida
Makiko
M
Morita
Ryoko
R
Lefor
Alan T
AT
Nabeshima
Toshitaka
T
D000368:Aged; D000369:Aged, 80 and over; D000583:Amikacin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology; D001831:Body Temperature / Q000187:drug effects; D002097:C-Reactive Protein / Q000032:analysis; D003404:Creatinine / Q000097:blood; D003428:Cross Infection / Q000097:blood / Q000188:drug therapy / Q000382:microbiology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006268:Health Facilities; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007677:Kidney Function Tests; D007958:Leukocyte Count; D008134:Long-Term Care; D008297:Male; D012141:Respiratory Tract Infections / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000583:Amikacin; D002097:C-Reactive Protein; D003404:Creatinine